July 14, 2003Journal of Clinical Oncology3,086 citations
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
View Full Paper
Key Points
Key points are not available for this paper at this time.
Abstract
Treatment with pemetrexed plus cisplatin and vitamin supplementation resulted in superior survival time, time to progression, and response rates compared with treatment with cisplatin alone in patients with malignant pleural mesothelioma. Addition of folic acid and vitamin B12 significantly reduced toxicity without adversely affecting survival time.
Cite This Study
Vogelzang et al. (2003) studied this question.